Cover Image
Market Research Report

Serodus ASA - Product Pipeline Review - 2015

Published by Global Markets Direct Product code 293936
Published Content info 30 Pages
Immediate Delivery Available
Price
Back to Top
Serodus ASA - Product Pipeline Review - 2015
Published: August 26, 2015 Content info: 30 Pages
Description

Summary

Global Markets Direct's, 'Serodus ASA - Product Pipeline Review - 2015', provides an overview of the Serodus ASA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Serodus ASA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Serodus ASA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Serodus ASA's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Serodus ASA's pipeline products

Reasons to buy

  • Evaluate Serodus ASA's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Serodus ASA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Serodus ASA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Serodus ASA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Serodus ASA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Serodus ASA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Table of Contents
Product Code: GMDHC07468CDB

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Serodus ASA Snapshot
    • Serodus ASA Overview
    • Key Information
    • Key Facts
  • Serodus ASA - Research and Development Overview
    • Key Therapeutic Areas
  • Serodus ASA - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Serodus ASA - Pipeline Products Glance
    • Serodus ASA - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Serodus ASA - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Serodus ASA - Drug Profiles
    • SER-100
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SER-150
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SER-130
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SER-140
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Serodus ASA - Pipeline Analysis
    • Serodus ASA - Pipeline Products by Target
    • Serodus ASA - Pipeline Products by Route of Administration
    • Serodus ASA - Pipeline Products by Molecule Type
    • Serodus ASA - Pipeline Products by Mechanism of Action
  • Serodus ASA - Recent Pipeline Updates
  • Serodus ASA - Dormant Projects
  • Serodus ASA - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • piboserod hydrochloride
      • SER-101
  • Serodus ASA - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Serodus ASA, Key Information
  • Serodus ASA, Key Facts
  • Serodus ASA - Pipeline by Indication, 2015
  • Serodus ASA - Pipeline by Stage of Development, 2015
  • Serodus ASA - Monotherapy Products in Pipeline, 2015
  • Serodus ASA - Phase II, 2015
  • Serodus ASA - Phase I, 2015
  • Serodus ASA - Preclinical, 2015
  • Serodus ASA - Pipeline by Target, 2015
  • Serodus ASA - Pipeline by Route of Administration, 2015
  • Serodus ASA - Pipeline by Molecule Type, 2015
  • Serodus ASA - Pipeline Products by Mechanism of Action, 2015
  • Serodus ASA - Recent Pipeline Updates, 2015
  • Serodus ASA - Dormant Developmental Projects,2015
  • Serodus ASA - Discontinued Pipeline Products, 2015

List of Figures

  • Serodus ASA - Pipeline by Top 10 Indication, 2015
  • Serodus ASA - Pipeline by Stage of Development, 2015
  • Serodus ASA - Monotherapy Products in Pipeline, 2015
  • Serodus ASA - Pipeline by Top 10 Target, 2015
  • Serodus ASA - Pipeline by Top 10 Route of Administration, 2015
  • Serodus ASA - Pipeline by Top 10 Molecule Type, 2015
  • Serodus ASA - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top